4//SEC Filing
HALAS GUS D 4
Accession 0001213900-22-032529
CIK 0001448431other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:45 PM ET
Size
5.7 KB
Accession
0001213900-22-032529
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
HALAS GUS D
Director
Transactions
- Award
Restricted Stock Units
2022-06-09+4,637→ 4,637 total→ Common Stock (4,637 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
- [F2]The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001230322
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:45 PM ET
- Size
- 5.7 KB